Editorial: The developments of metal-based agents against lung cancer
Front Pharmacol
.
2022 Dec 8:13:1101890.
doi: 10.3389/fphar.2022.1101890.
eCollection 2022.
Authors
Yi Gou
1
,
Li Liu
2
,
Hong Liang
3
Affiliations
1
Laboratory of Respiratory Disease, Guilin Medical University, Guilin, China.
2
University of Texas Southwestern Medical Center, Dallas, TX, United States.
3
Guangxi Normal University, Guilin, China.
PMID:
36569321
PMCID:
PMC9773868
DOI:
10.3389/fphar.2022.1101890
No abstract available
Keywords:
activity evaluation; anticancer; design; lung cancer; metal-based agents.
Publication types
Editorial